Synthetic apelin treatment to mice during the development of DSS-induced colitis significantly enhanced the proliferation of colonic epithelial cells, suggesting that enhanced apelin expression in the intestinal recovery stage may result in the repair of the intestinal epithelium in rodent colitis models and in patients with IBD [114]. This evidence concerns the gene APLN and inflammatory bowel disease.